Adjuvant therapy of breast cancer with o
β
Aman U. Buzdar; Gabriel N. Hortobagyi; Terry L. Smith; Shu Kau; Connie Marcus; F
π
Article
π
1988
π
John Wiley and Sons
π
English
β 642 KB
Three hundred ten patients with Stage I1 or Stage 111 breast cancer were entered on an adjuvant protocol consisting of a combination of 5-fluorouracil, doxorubicin, cyclophosphamide, vincristine, and prednisone (FACVP). In the second phase of the study, patients with estrogen receptor-negative tumor